112 related articles for article (PubMed ID: 30380169)
1. How Many Cores Does Systematic Prostate Biopsy Need?: A Large-Sample Retrospective Analysis.
Hu Z; Wang J; Sun D; Cui L; Ran W
J Ultrasound Med; 2019 Jun; 38(6):1491-1499. PubMed ID: 30380169
[TBL] [Abstract][Full Text] [Related]
2. Targeted Biopsy With Reduced Number of Cores: Optimal Sampling Scheme in Patients Undergoing Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy.
Shen WW; Cui LG; Ran WQ; Sun Y; Jiang J; Pei XL; Chen W
Ultrasound Med Biol; 2020 May; 46(5):1197-1207. PubMed ID: 32107089
[TBL] [Abstract][Full Text] [Related]
3. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.
Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T
Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486
[TBL] [Abstract][Full Text] [Related]
6. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?
Liu H; Ruan M; Wang H; Wang H; Li X; Song G
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):589-595. PubMed ID: 32719353
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
[TBL] [Abstract][Full Text] [Related]
8. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer.
Hanna N; Wszolek MF; Mojtahed A; Nicaise E; Wu B; Gelpi-Hammerschmidt FJ; Salari K; Dahl DM; Blute ML; Harisinghani M; Feldman AS
J Urol; 2019 Nov; 202(5):944-951. PubMed ID: 31144593
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients.
Oderda M; Marra G; Albisinni S; Altobelli E; Baco E; Beatrici V; Cantiani A; Carbone A; Ciccariello M; Descotes JL; Dubreuil-Chambardel M; Eldred-Evans D; Fasolis G; Ferriero M; Fiard G; Forte V; Giacobbe A; Kumar P; Lacetera V; Mozer P; Muto G; Papalia R; Pastore A; Peltier A; Piechaud T; Simone G; Roche JB; Roupret M; Rouviere O; Van Velthoven R; Gontero P
Int J Urol; 2018 Dec; 25(12):990-997. PubMed ID: 30187529
[TBL] [Abstract][Full Text] [Related]
11. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?
Dimitroulis P; Rabenalt R; Nini A; Hiester A; Esposito I; Schimmöller L; Antoch G; Albers P; Arsov C
J Urol; 2018 Nov; 200(5):1030-1034. PubMed ID: 29733837
[TBL] [Abstract][Full Text] [Related]
14. Value of Increasing Biopsy Cores per Target with Cognitive MRI-targeted Transrectal US Prostate Biopsy.
Zhang M; Milot L; Khalvati F; Sugar L; Downes M; Baig SM; Klotz L; Haider MA
Radiology; 2019 Apr; 291(1):83-89. PubMed ID: 30694165
[TBL] [Abstract][Full Text] [Related]
15. MRI-TRUS fusion guided prostate biopsy - initial experience and assessment of the role of contralateral lobe systematic biopsy.
Andras I; Crisan D; Cata E; Tamas-Szora A; Caraiani C; Coman RT; Bungardean C; Mirescu C; Coman I; Crisan N
Med Ultrason; 2019 Feb; 21(1):37-44. PubMed ID: 30779829
[TBL] [Abstract][Full Text] [Related]
16. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
[TBL] [Abstract][Full Text] [Related]
17. Strain Elastography-Targeted Biopsy: Does Prostate Volume Affect Prostate Cancer Detection?
Zhu YC; Shan J; Zhang Y; Jiang Q; Wang YB; Deng SH; Qu QH; Li Q
Med Sci Monit; 2019 Nov; 25():8836-8842. PubMed ID: 31754091
[TBL] [Abstract][Full Text] [Related]
18. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
19. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
[TBL] [Abstract][Full Text] [Related]
20. Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients.
Ullrich T; Arsov C; Quentin M; Laqua N; Klingebiel M; Martin O; Hiester A; Blondin D; Rabenalt R; Albers P; Antoch G; Schimmöller L
Eur J Radiol; 2019 Apr; 113():1-6. PubMed ID: 30927932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
